You are here

Article info

Article menu
XML
Hepatology
Original article
LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours

Authors

  1. Correspondence to Robert H Wiltrout, Experimental Therapeutics Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick MD 21702, USA; wiltrour{at}mail.nih.gov
View Full Text

Citation

Scarzello AJ, Jiang Q, Back T, et al
LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours
Gut 2016;65:1765-1775.

Publication history

  • Received November 10, 2014
  • Revised April 29, 2015
  • Accepted May 16, 2015
  • First published July 23, 2015.
Online issue publication 
September 08, 2016

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/